UPC CFI 463/2024

Aug 30, 2024·EP2493466 · NOVEL ANTITUMORAL USE OF CABAZITAXEL

Case details: Status
Case Closed
Action
Counterclaim for revocation
Category
Counterclaim for revocation
Parties: Claimants
Accord Healthcare S.L.U.Operating co.
Accord Healthcare B.V.Operating co.
Accord Healthcare GmbHOperating co.
Accord Healthcare Italia SrlOperating co.
Accord Healthcare, Unipessoal Lda.Operating co.
Accord Healthcare ABOperating co.
Representatives
Jules Fabre-Pinsent Masons
Respondents
Sanofi Mature IPOperating co.
Representatives
Frédéric Chevallier-Herbert Smith Freehills Kramer LLP
Division: Munich LD
Judges: Matthias Zigann
Alima Zana
Tobias Pichlmaier
Technology: Chemistry
Pharmaceuticals
Language: English
EPO Opposition: Glenmark Pharmaceuticals Europe Ltd2021-03-10
Accord Healthcare LtdAdmissible2021-03-10
Teva Pharmaceutical Industries Ltd.Admissible2021-03-10
EVER Valinject GmbHWithdrawn2021-03-12
Zentiva k.s.Admissible2021-03-12
medac Gesellschaft für klinische Spezialpräparate mbHWithdrawn2021-03-22
Fresenius Kabi Deutschland GmbHAdmissible2021-03-23
Dr. Reddy's Laboratories Ltd.Admissible2021-03-31
Betapharm Arzneimittel GmbHAdmissible2021-03-31
Generics (U.K.) LimitedAdmissible2021-06-08
Vossius & Partner Patentanwälte Rechtsanwälte mbBAdmissible2021-12-03
STADA Arzneimittel AGAdmissible2021-12-09
Maiwald GmbHAdmissible2021-12-10
Accord Healthcare S.L.U.2024-08-30

How this compares

The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.

	Patent revoked	Median days to first decision
All UPC	37% (34/91)	124
Munich LD	Locked	Locked
Judge Matthias Zigann	Locked	Locked
Judge Alima Zana	Locked	Locked
Judge Tobias Pichlmaier	Locked	Locked

At the UPC: Accord Group (8 cases)·Sanofi Group (33 cases)

Related cases

More cases: Munich LD·2024

Documents